Novartis

Novartis to buy French cancer specialist AAA for $3.9 billion
Yahoo/Reuters
Mon, 10/30/17 - 09:58 am
Novartis
M&A
France
Advanced Accelerator Application
radiopharmaceuticals
oncology
Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
GoinPharma
Thu, 10/26/17 - 10:51 am
Novartis
Alcon
spinoffs
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
JNJ
Roche
Pfizer
Novartis
Merck
Serono
AbbVie
Sanofi
Amgen
Bayer
GSK
Sandoz raises questions with FDA draft guidance on statistical approaches for biosimilars
Endpoints
Wed, 10/25/17 - 10:59 am
Sandoz
Novartis
FDA
biosimilars
Eyes on Alcon as Novartis notches modest growth
Biopharma Dive
Tue, 10/24/17 - 05:31 pm
Novartis
earnings
Alcon
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Yahoo/Zacks.com
Mon, 10/23/17 - 09:59 am
earnings
Eli Lilly
Biogen
Novartis
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
Mon, 10/23/17 - 09:57 am
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Fierce Pharma
Thu, 10/19/17 - 09:12 am
Gilead Sciences
Kite Pharma
Novartis
CAR-T
FDA
axi-cel
Yescarta
non-Hodgkin's lymphoma
large B-cell lymphoma
Novartis division closing Broomfield operations
Broomfield Enterprise, Colorado
Tue, 10/17/17 - 09:46 am
Novartis
drug manufacturing
Sandoz
generics
Corrected: What Q3 earnings will look like for 5 pharma giants
Biopharma Dive
Sat, 10/14/17 - 11:33 am
earnings
JNJ
Roche
Biogen
Eli Lilly
Novartis
No sale for Novartis' $14B Roche stake, but the revamp's not done
Fierce Pharma
Thu, 10/12/17 - 10:11 pm
Novartis
Roche
Here Come More Gene Therapies -- And More Pricing Debates
Forbes
Wed, 10/11/17 - 10:03 am
gene therapies
drug pricing
Luxturna
Spark Therapeutics
Kymriah
Novartis
In Novartis' newest Cosentyx push, active, real-life patients take center stage
Fierce Pharma
Mon, 10/9/17 - 10:54 am
Novartis
Cosentyx
drug ads
psoriatic arthritis
Lilly wards off another Alimta patent challenge, this time through IPR
Fierce Pharma
Fri, 10/6/17 - 11:42 am
Eli Lilly
Alimta
patents
IPR
lung cancer
Neptune
generics
Novartis
Sandoz
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
Fierce Pharma
Thu, 10/5/17 - 06:16 pm
Novartis
CAR-T
Vas Narasimhan
Japan
drug pricing
performance-based pricing
Big Pharma Doesn't Want Health Outcomes To Sway Pricing -- At Least Not Yet
Forbes
Fri, 09/29/17 - 11:53 am
Big Pharma
drug pricing
gene therapy
Novartis
Kymriah
Why would Novartis buy a $2.6B radiotherapy maker? Its neuroendocrine franchise, analyst says
Fierce Pharma
Thu, 09/28/17 - 06:28 pm
Novartis
radiotherapy
M&A
Advanced Accelerator Application
neuroendocrine
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval
Fierce Pharma
Thu, 09/28/17 - 06:24 pm
Eli Lilly
Pfizer
Novartis
Verzenio
breast cancer
Ibrance
Kisqali
Buyout buzz: Novartis has been kicking the tires at AAA as FDA reviews Lutathera — report
Endpoints
Thu, 09/28/17 - 11:08 am
Novartis
FDA
Lutathera
M&A
Advanced Accelerator Application
Premium price for Novartis' CAR-T sparks pushback from top PBM
BioPharma Dive
Mon, 09/25/17 - 07:23 pm
Novartis
Kymriah
CAR-T
drug pricing
Express Scripts
PBMs

Pages